Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3698514013 | Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3698515014 | Nicotine (as nicotine cyclodextrin complex) 2 mg sublingual tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Has basis of strength substance | Nicotine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Is a | Product manufactured as oromucosal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Has manufactured dose form | Conventional release sublingual tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Has precise active ingredient | Nicotine cyclodextrin complex | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Is a | Product containing nicotine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet | Is a | Product containing only nicotine in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR